DM
PRQR icon

Deerfield Management’s ProQR Therapeutics PRQR Stock Holding History

Deerfield Management’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-209,398
Closed -$3.05M – 122
2015
Q3 		$3.05M Hold
209,398
– – 0.12% 103
2015
Q2 		$3.49M Hold
209,398
– – 0.12% 101
2015
Q1 		$4.58M Sell
209,398
-170,602
-45% -$3.52M 0.15% 86
2014
Q4 		$8.23M Sell
380,000
-150,000
-28% -$2.28M 0.3% 65
2014
Q3 		$9.11M Buy
+530,000
New +$8.49M 0.33% 73

Other funds holding PRQR

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM

Deerfield Management's PRQR Position: Q4 2015 in Review

Deerfield Management sold out of ProQR Therapeutics (PRQR) in Q4 2015, closing a stake of 209,398 shares — an estimated $3.05M sold.

Deerfield Management first reported a position in PRQR in Q3 2014 and held it in 5 quarters. The position peaked at $9.11M in Q3 2014. 32 funds tracked by Wall St. Rank hold PRQR as of Q4 2015.

  • Deerfield Management reported no remaining ProQR Therapeutics position as of Q4 2015 after selling out during the quarter.
  • Deerfield Management sold 209,398 ProQR Therapeutics shares in Q4 2015, an estimated $3.05M.
  • Deerfield Management first reported a position in ProQR Therapeutics in Q3 2014 and held it in 5 quarters.
  • Deerfield Management's ProQR Therapeutics position peaked at $9.11M in Q3 2014.
  • 32 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q4 2015.

Based on Deerfield Management's 13F filing for Q4 2015, filed 16 Feb 2016.